Related Experiment Video
Updated: Aug 30, 2026

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
Role of GRP58 in mitomycin C-induced DNA cross-linking
Claudia M Celli1, Anil K Jaiswal
1Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030, USA.
Abstract:
Mitomycin C (MMC) is an anticancer drug that requires reductive activation to exert its toxicity. MMC is known to cross-link DNA that contributes significantly to the cytotoxicity and consequent cell death. Cytosolic NADPH:quinone oxidoreductase 1 (NQO1) and microsomal enzymes have been shown to mediate MMC-induced DNA cross-linking. However, NQO1 plays only a minor role, indicating presence of other cytosolic enzymes/proteins that contribute to this process. In this study, we have characterized a unique cytosolic activity in NQO1-null mice that catalyzed MMC-induced DNA cross-linking. This activity was cofactor independent and dicoumarol insensitive. The unique cytosolic activity was purified to homogeneity. The peptide sequencing of the purified protein identified the unique cytosolic activity as GRP58 (M(r) 58,000 glucose-regulatory protein), also known as GRp57/ER60/ERp61/HIP-70/Q2 and CPT. Immunodepletion of NQO1-null mice liver cytosol and partially purified fractions with anti-GRP58 antibody led to a complete loss of GRP58 protein and consequent significant reduction of MMC-induced DNA cross-linking. Mouse cDNA encoding GRP58 was isolated and sequenced. Chinese hamster ovary cells permanently overexpressing GRP58 showed increased MMC-induced DNA cross-linking and increased cytotoxicity on exposure to MMC. Bacterially expressed and purified GRP58 increased the MMC-induced DNA cross-linking when added to mouse cytosolic samples. A tissue array analysis indicated that GRP58 is ubiquitously expressed among mouse tissues, although at different levels. Expression analysis using matched human tumor/normal array revealed an up-regulation of GRP58 in breast, uterus, lung, and stomach tumors compared with normal tissues of similar origin.
Insights
Researchers identified glucose-regulatory protein 58 (GRP58) as a key enzyme in activating the anticancer drug Mitomycin C (MMC). GRP58 enhances MMC-induced DNA cross-linking and cytotoxicity, offering a new target for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Mitomycin C (MMC) is an anticancer drug requiring reductive activation for its cytotoxic effects.
- DNA cross-linking by MMC is a primary mechanism for cell death, with NQO1 and microsomal enzymes implicated in its activation.
- NQO1's minor role suggests other cytosolic factors contribute significantly to MMC-induced DNA cross-linking.
Purpose of the Study:
- To identify and characterize the unique cytosolic activity responsible for Mitomycin C (MMC)-induced DNA cross-linking in NQO1-null mice.
- To elucidate the role of Glucose-Regulatory Protein 58 (GRP58) in MMC activation and its potential as a therapeutic target.
Main Methods:
- Purification and peptide sequencing of the unique cytosolic activity from NQO1-null mouse liver cytosol.
- Immunodepletion assays using anti-GRP58 antibodies to assess its role in MMC-induced DNA cross-linking.
- Overexpression studies in Chinese hamster ovary (CHO) cells and functional assays with bacterially expressed GRP58.
- Tissue array analysis to determine GRP58 expression in mouse tissues and human tumors.
Main Results:
- A unique, cofactor-independent, and dicoumarol-insensitive cytosolic activity was identified and purified.
- Peptide sequencing identified this activity as Glucose-Regulatory Protein 58 (GRP58).
- Immunodepletion of GRP58 abolished MMC-induced DNA cross-linking, confirming its essential role.
- GRP58 overexpression in CHO cells increased MMC-induced DNA cross-linking and cytotoxicity.
- GRP58 is ubiquitously expressed in mouse tissues and upregulated in human breast, uterus, lung, and stomach tumors.
Conclusions:
- Glucose-Regulatory Protein 58 (GRP58) is a critical enzyme mediating reductive activation of Mitomycin C (MMC).
- GRP58 significantly contributes to MMC-induced DNA cross-linking and cytotoxicity.
- GRP58's upregulation in various human tumors suggests its potential as a predictive biomarker and therapeutic target in cancer treatment.
Related Concept Videos
Homologous Recombination
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Restarting Stalled Replication Forks
Nucleotide Excision Repair

